Evidity Health Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
GT Medical TechnologiesMay 2026
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)Jason Rostovsky(Director)James Leech(Executive Officer)Radu Cautis(Director)Matthew E. Likens(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.